A series of isoxazolidines has been synthesized as mimetics of the RGD sequ
ence and was evaluated as antagonists of the platelet glycoprotein IIb/IIIa
receptor. These compounds were shown to be highly potent GPIIb/IIIa antago
nists, exhibiting submicromolar potencies. (C) 1998 The DuPont Pharmaceutic
als Company. Published by Elsevier Science Ltd. All rights reserved.